Predominance of CD4+ T cells and Th2 cytokines in the pericardial fluid of a dermatomyositis patient with cardiac tamponade.
A
A
Martínez
L M
LM
Vilá
E
E
Ríos-Olivares
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology*; D002305:Cardiac Tamponade / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D016207:Cytokines / Q000378:metabolism*; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D010490:Pericardial Effusion / Q000378:metabolism / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use; D018418:Th2 Cells / Q000276:immunology*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D011241:Prednisone; D008775:Methylprednisolone